Clinical trial
A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis.
NCT07503197 is registered in ClinicalTrials.gov with Institute of Dermatology, Thailand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis.
- Lead sponsor
- Institute of Dermatology, Thailand
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- April 1, 2026
- Completion date
- February 14, 2027
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis (ad), cholesterol, eczema atopic dermatitis, skin allergy, skin barrier to water loss, trans epidermal water loss